There are now some 935,392 cases of coronavirus infection globally,
as of the last Reuters tally on Thursday, meaning the 1 million mark
will be surpassed in the next 24 hours at the current rate of
increase. Given the widespread recognition that official national
figures in many cases woefully under-represent the true spread of
the virus, the real figure will be much higher. The death toll
continues to rise sharply, with nearly 5,000 confirmed new
fatalities in the last day for a total of 46,906. One small solace
is that massive under-detection means the actual mortality rate -
deaths divided by cases - is likely a lot lower than official
figures imply.
(For an interactive graphic tracking the global spread, open
https://tmsnrt.rs/3aIRuz7 in an external browser.)
Not working: labour markets suffer
Social security data released by Spain on Thursday underline the
economic and human cost of measures put in place to arrest the
spread of the virus: they reveal that the country has shed close to
900,000 jobs since it went into lockdown in mid-March. That is the
highest monthly rise in unemployment ever, faster even than when
Spain was in the eye of the storm of the 2008/2009 global recession.
U.S. data out later on Thursday will be equally grim: economists
surveyed by Reuters expect on average that U.S. jobless claims will
jump by about 3.5 million for March 22-28 week as lockdowns of
cities mean there is even less likelihood of hiring than during a
recession.
Things not under control
European Union governments may have worsened their current
predicament of mask and medical equipment shortages by
overestimating their response capacity, internal and public
documents seen by Reuters show.
"There is strong level of preparedness in member states, most have
measures in place" to detect and treat COVID-19, a European
Commission official said at a closed-door meeting with diplomats
from member states on Feb. 5, two weeks after China locked down
nearly 60 million people in Hubei province, or roughly the
equivalent population of Italy.
[to top of second column] |
EU governments began to realise the gravity of the situation in March, but
rather than focusing on joint action, many resorted to protectionist measures,
raising trade barriers to hinder the export of medical equipment to their
neighbours.
Isolating antibodies 'effective' at blocking coronavirus
A team of Chinese scientists has isolated several antibodies that it says are
"extremely effective" at blocking the ability of the new coronavirus to enter
cells, which eventually could be helpful in treating or preventing COVID-19.
Zhang Linqi at Tsinghua University in Beijing said a drug made with antibodies
like the ones his team have found could be used more effectively than current
approaches, including those utilising plasma, which is restricted by blood type.
The team is now focused on identifying the most powerful antibodies and possibly
combining them to mitigate the risk of the new coronavirus mutating.
If all goes well, interested developers could mass produce them for testing,
first on animals and eventually on humans.
(Open https://reut.rs/2JuUzGt in an external browser to see an interactive
graphic that tracks the spread of coronavirus in your country.)
'Shoot them dead' - Philippines president warns lockdown violaters
Philippine President Rodrigo Duterte said violaters of the country's coronavirus
lockdown measures could be shot for causing trouble and that abuse of medical
workers was a serious crime that wouldn't be tolerated.
"My orders to the police and military ... if there is trouble and there's an
occasion that they fight back and your lives are in danger, shoot them dead," he
said in a televised address late on Wednesday.
"Is that understood? Dead. Instead of causing trouble, I will bury you."
Duterte's office typically calls his remarks hyperbole to underline his point.
(Compiled by Karishma Singh and Mark John)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |